GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (NAS:OPK) » Definitions » Beneish M-Score

OPKO Health (OPKO Health) Beneish M-Score

: -3.05 (As of Today)
View and export this data going back to 1995. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.05 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for OPKO Health's Beneish M-Score or its related term are showing as below:

OPK' s Beneish M-Score Range Over the Past 10 Years
Min: -3.1   Med: -2.71   Max: 1.95
Current: -3.05

During the past 13 years, the highest Beneish M-Score of OPKO Health was 1.95. The lowest was -3.10. And the median was -2.71.


OPKO Health Beneish M-Score Historical Data

The historical data trend for OPKO Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.66 -1.82 -2.69 -2.98 -3.05

OPKO Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.98 -2.45 -2.00 -2.94 -3.05

Competitive Comparison

For the Diagnostics & Research subindustry, OPKO Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health Beneish M-Score Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where OPKO Health's Beneish M-Score falls into.



OPKO Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of OPKO Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0189+0.528 * 0.779+0.404 * 1.017+0.892 * 0.8599+0.115 * 1.115
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9379+4.679 * -0.071545-0.327 * 1.113
=-3.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $130.2 Mil.
Revenue was 181.904 + 178.595 + 265.418 + 237.577 = $863.5 Mil.
Gross Profit was 44.707 + 47.677 + 126.479 + 99.263 = $318.1 Mil.
Total Current Assets was $309.5 Mil.
Total Assets was $2,011.7 Mil.
Property, Plant and Equipment(Net PPE) was $143.5 Mil.
Depreciation, Depletion and Amortization(DDA) was $105.3 Mil.
Selling, General, & Admin. Expense(SGA) was $300.6 Mil.
Total Current Liabilities was $200.1 Mil.
Long-Term Debt & Capital Lease Obligation was $283.4 Mil.
Net Income was -66.483 + -84.473 + -19.64 + -18.267 = $-188.9 Mil.
Non Operating Income was -0.888 + -10.432 + -21.241 + 15.822 = $-16.7 Mil.
Cash Flow from Operations was -38.294 + 33.109 + -0.365 + -22.647 = $-28.2 Mil.
Total Receivables was $148.6 Mil.
Revenue was 185.34 + 179.744 + 309.893 + 329.219 = $1,004.2 Mil.
Gross Profit was 55.994 + 31.299 + 115.582 + 85.344 = $288.2 Mil.
Total Current Assets was $394.5 Mil.
Total Assets was $2,167.3 Mil.
Property, Plant and Equipment(Net PPE) was $121.6 Mil.
Depreciation, Depletion and Amortization(DDA) was $108.7 Mil.
Selling, General, & Admin. Expense(SGA) was $372.7 Mil.
Total Current Liabilities was $213.5 Mil.
Long-Term Debt & Capital Lease Obligation was $254.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(130.2 / 863.494) / (148.608 / 1004.196)
=0.150783 / 0.147987
=1.0189

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(288.219 / 1004.196) / (318.126 / 863.494)
=0.287015 / 0.368417
=0.779

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (309.476 + 143.517) / 2011.698) / (1 - (394.525 + 121.604) / 2167.259)
=0.774821 / 0.761852
=1.017

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=863.494 / 1004.196
=0.8599

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(108.655 / (108.655 + 121.604)) / (105.297 / (105.297 + 143.517))
=0.471882 / 0.423196
=1.115

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(300.559 / 863.494) / (372.672 / 1004.196)
=0.348073 / 0.371115
=0.9379

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((283.448 + 200.052) / 2011.698) / ((254.521 + 213.48) / 2167.259)
=0.240344 / 0.215941
=1.113

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-188.863 - -16.739 - -28.197) / 2011.698
=-0.071545

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

OPKO Health has a M-score of -3.05 suggests that the company is unlikely to be a manipulator.


OPKO Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of OPKO Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health (OPKO Health) Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.
Executives
Frost Phillip Md Et Al 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Hsiao Jane Ph D director 4400 BISCAYNE BLVD, MIAMI FL 33137
Gary J. Nabel director, officer: Chief Innovation Officer C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Elias A. Zerhouni director, officer: Vice Chairman and President 2099 PENNSYLVANIA AVENUE, NW 12TH FLOOR, WASHINGTON DC 20006
John A Paganelli director, other: Chairman of the Board OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Steven D Rubin director OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Pfenniger Richard C Jr director 4400 BISCAYNE BLVD., MIAMI FL 33137
Alexis Borisy director C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 16TH FLOOR, CAMBRIDGE MA 02142
Jon R Cohen director, officer: SVP OPKO; Exec Chairman BRLI C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Prem A Lachman director 4400 BISCAYNE BLVD., MIAMI FL 33137
Roger Md Medel director 1301 CONCORD TERRACE, SUNRISE FL 33323
Rulfo Fernando Hernandez officer: CAO, Treasurer C/O OPKO HEALTH INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Anthony J Japour director 19805 N. CREEK PARKWAY, BOTHELL WA 98011
Robert Scott Fishel director C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Adam Logal officer: Exec.Dir .of Fin., CAO,Treas. OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137